PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1284176
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1284176
According to Stratistics MRC, the Global Natural Vitamin-E Market is accounted for $865.32 million in 2022 and is expected to reach $1435.34 million by 2028 growing at a CAGR of 8.8% during the forecast period. Vitamin E is a fat-soluble antioxidant that protects the cell membrane from reactive oxygen species. It can be found in various foods, including vegetable oil, fruits and vegetables, meat, cereal, poultry eggs, and wheat germ oil. Vitamin E insufficiency is common in persons with genetic disorders or premature newborns. Vitamin E-rich foods include olive, canola, almonds, margarine, and peanuts. Meats, leafy greens, dairy, and fortified cereals are other good sources of natural vitamin E.
According to Food and Agriculture Organization, Mexico, the largest milk producer in Central America, continues to invest in producing better-quality animal feed with incorporated nutrients to maintain productivity, thereby driving the demand for natural Vitamin E ingredients.
The increased demand for vitamin supplements is likely to cause a significant increase in the global market for natural vitamin E during the forecast period. A substantial body of clinical research backs up the importance of vitamins for overall health and their advantages for the human body, especially the bones. Sales of natural vitamin E-based goods, including pharmaceutical-grade injections, oral supplements, food fortification, and dietary supplements, will be boosted by this factor, which will accelerate market growth over the course of the forecast period.
Vitamin E inhibits platelet aggregation, which reduces blood clotting. If you take blood thinners, such as Coumadin (warfarin) or Plavix (clopidogrel), consult your doctor before taking vitamin E, especially if you have poor vitamin K consumption. Furthermore, avoid taking vitamin E at least two weeks before surgery to prevent excessive bleeding. Excessive usage of vitamin E has several side effects which may challenge the market's growth as it causes blood thinning and deadly hemorrhage. The supply chain disruption caused to several political and natural causes has further affected product availability, which may be a significant barrier to market growth over the forecast period.
One of the key factors driving market expansion is the increasing prevalence of chronic disorders. The increased prevalence of chronic diseases such as diabetes, obesity, cholesterol-related osteoarthritis, and cardiovascular diseases (CVDs) is expected to raise the need for vitamin E supplements over the projected period. People with macular degeneration, Crohn's disease, and cystic fibrosis need to take vitamin E medication to prevent problems with breathing, digestion, weight loss, gastrointestinal infections, and trouble absorbing nutrients. Due to its powerful antioxidant properties, which support the immune system's vigor and help prevent blood clots, the body needs it. Additionally, the anti-inflammatory system protects cells from free radicals. This has inspired experts to dig deeper into vitamin E's therapeutic potential.
Vitamin E usage in excess can thin the blood and result in fatal haemorrhages. Market expansion is being hampered by supply chain instability, fluctuating raw material prices, and growing production costs. There are a number of side effects that are related to pill dose. Bleeding, fatigue, headaches, and nausea are possible side effects. In e-cigarettes and other vamping products, vitamin E acetate can be discovered. This vitamin has been linked to lung harm. The demand for vitamin E products is being constrained by these factors.
During the projection period, COVID-19's increased prevalence is anticipated to have an effect on market expansion. The healthcare sector has been directly and significantly impacted by the COVID-19 situation. The majority of pharmaceutical and nutraceutical companies recorded a minor loss in the first few quarters as a result of the rapid impact on the supply chain and limits placed on manufacturing and supply operations during the early phases of the coronavirus outbreak. The demand for nutraceuticals, such as natural vitamin E, has surged as a result of COVID-19, and some important players have enjoyed favourable sales development as a result.
The Tocopherols segment is projected to witness the largest share as compared to other segments over the forecast period. Highly fractionated D-alpha-tocopherols or its esters are the most common forms of vitamin E found in nature. Out of the eight chemical types known to exist, alpha-tocopherol is recognized to satisfy human nutritional needs. Due to the availability of tocopherols in most diets as opposed to tocotrienols, tocotrienols are a less prevalent type of vitamin-E. So, more tocopherols are used in the design and development of dietary supplements. Additionally, the use of tocopherols in cosmetic goods has grown. Since tocopherols are a good source of vitamin E and protect the skin from numerous harmful effects, notably from sun radiation, the cosmetics industry uses them frequently in its products.
The market saw dietary supplements as the top application sector. Most micronutrients can be found in isolated and purified concentrations on the international market. One of the most popular vitamin E product formats is pills and tablets, which are isolated and purified concentrations. The market for nutraceuticals is gradually changing in favour of fortified meals as a means of achieving maximal nutrient penetration among the general population. Therefore, fortified foods are practical, affordable, accessible, and safe platforms for the inclusion of micronutrients like vitamin E, which is a crucial factor fostering the expansion of the global market.
The world market for naturally occurring vitamin E is anticipated to be dominated by North America in the upcoming forecast period. Increasing patterns of medical spending, aging, increased technology, better healthcare facilities, and an increase in the number of insured people are all present in North American countries, including the United States. These elements enable the application of vitamin E in a range of end-user industries. Functional foods that offer extra advantages for health and wellness have also greatly expanded the market. An increase in the older population, rising health care expenditures, changes in lifestyle, and the development of new foods have all contributed to market expansion. This made it possible for producers of functional foods to identify components that offered enhanced advantages and could potentially satisfy rising demand.
During the forecast period, Asia-Pacific is anticipated to have the fastest growth rate. Consumer awareness of the health advantages of various vitamin kinds is causing the vitamin market in Asia-Pacific nations to shift quickly. In the Asia-Pacific region, China produces the most vitamin E. In recent years, the nation has also grown its domestic market, mostly as a result of the expanding pharmaceutical and dietary supplement industries nationwide. Additionally, just 9% of Indian customers are aware of the health advantages of vitamin E, despite an increase in understanding of the significance of various vitamins in nations like India. While the majority of people use vitamin E to treat common illnesses, widespread ignorance prevents vitamin E from reaching its full potential.
Some of the key players in Natural Vitamin-E Market include Adama Agricultural Solutions Ltd., Archer Daniels Midland Company, BASF SE, Bayer AG, Beijing Gingko Group, Davos Life Science, DLF Seeds A/S, DSM, DuPont., Eisai Co., Ltd., FenchemBiotek, Hangzhou Gosun Biotech Co. Ltd, Koninklijke DSM N.V., KWS SAAT SE & Co. KGaA, Land O'Lakes, Inc., Merck KGaA, Monsanto Company, Orah Nutrichem, Orochem Technologies Inc., Parchem fine & specialty chemicals, Prinova Group LLC, Rijk Zwaan Zaadteelt en Zaadhandel B.V., RIKEN VITAMIN Co., Ltd., Sakata Seed America., Southwest Synthetic Pharmaceuticals Corp Ltd., Syngenta Crop Protection AG, TAKII & CO.,LTD., The Bountiful Company, Vance Group, VILMORIN & CIE, Wilmar International Limited and Zhejiang Worldbestve Biotechnology Co., Ltd.
In December 2021, Kensing announced cooperation with Azelis to improve and expand the distribution of vegetable oils, vitamins, and personal care goods throughout Europe, the Middle East, and Africa. In the B2B market, Azelis has a significant distribution network in these locations.
In June 2021, One Rock Capital acquired the specialty chemical facility and other business segments from BASF in Kankakee, Illinois, United States. The firm aims to upgrade the facility and manufacture vegetable oils, natural vitamin E, and other specialty chemicals in the plant.
In June 2021, Prinova developed an e-commerce website to improve ingredient procurement in the United States. Food-grade vitamins and amino acids are available on the internet. The company seeks to supply B2B vitamin distribution solutions worldwide.
In Dec 2019, Koninklijke DSM NV announced a joint venture with Nenter & Co Inc., which includes all of the latter's products and related assets for vitamin E.